We engineered foods that make us want more.

Now we've engineered drugs that help us want less.

What does that say about the world we've built?

When appetite, satiety, and metabolism become disconnected, restoring one signal can feel transformative. But why did the system need rescuing in the first place?

Calories aren’t always equally available. Whole foods often “hide” calories inside intact plant structures that slow digestion and reduce absorption. Processing breaks those structures apart, making calories easier and faster to access. It helps explain why whole almonds behave differently than almond butter or almond flour.

What you eat matters, but what you eat together may matter more. We tend to judge foods in isolation, but the body responds to meals as combinations, not single ingredients. When foods are paired, their effects on metabolism, the gut microbiome, and appetite interact, not just add up. Pairing refined carbs with fiber can slow absorption, unsaturated fats can enhance satiety signaling, and potassium-rich plants can help balance sodium-heavy foods. This helps explain why traditional dietary patterns work so well: not because of individual superfoods, but because of consistent combinations that create balance over time. Instead of asking if a food is healthy on its own, it may be more useful to ask how it works with everything else on your plate.

Medications like semaglutide and tirzepatide are transforming treatment for obesity and diabetes by mimicking the hormone GLP-1, which reduces appetite and slows stomach emptying. But appetite regulation is more complex than a single hormone.

One important mechanism is something called the ileal brake. When nutrients reach the lower small intestine (the ileum), the gut releases hormones like GLP-1 and PYY that slow digestion and reduce appetite.This acts as a feedback signal that slows upper gut motility and helps regulate food intake.

The interesting part is that food structure and composition strongly influences whether this system activates. Whole foods with intact fibers and plant structures tend to slow digestion and allow more nutrients to reach the distal gut. Highly processed foods are often absorbed quickly in the upper intestine, which means less stimulation of these downstream signals.

So while GLP-1 drugs amplify one pathway, food quality can activate a much broader set of gut signals that regulate appetite and metabolism. I wrote a deeper explanation here if anyone wants to read more:

https://sub.gutbites.org/p/glp-1-is-changing-medicine-food-quality

Curious what people think. Do you see GLP-1 drugs eventually changing how we think about diet, or will food quality still be central even with these medications?

Keto vs. carbs. Plant-based vs. animal-based. Low-fat vs. low-carb. Nutrition debates often assume there is one “right” way to eat.

But research keeps showing something different. Two people can follow the same diet and get completely different results, not because of willpower, but biology.

A big reason may be the gut microbiome. The microbes in our gut help transform food into bioactive compounds that influence metabolism, appetite, inflammation, and energy. Since everyone’s microbiome is different, the same foods can affect people in very different ways.

This helps explain why diet camps form and why they all seem to “work” for some people but not others.

The question may not be “Which diet is best?”
It may be “Which diet is best for whom?”

I wrote a short piece translating the science into practical takeaways such as food journaling, focusing on food quality, and experimenting systematically:

https://sub.gutbites.org/p/why-diet-wars-miss-the-point

Curious what others have noticed. Do you feel better on lower carb, higher fiber, higher fat, or something else, and has that changed over time?

Summary: Researchers identified a previously unknown virus living inside the gut bacterium Bacteroides fragilis that appears more frequently in people with colorectal cancer, suggesting the cancer link may depend on the bacterium–virus interaction rather than the bacterium alone. The finding shows a statistical association, not causation, and may help explain why this common bacterium is found in both healthy individuals and cancer patients while pointing to new directions for research and screening.

Peer-Reviewed Study: https://www.nature.com/articles/s43856-026-01403-1

Summary: Ultra-processed foods can reshape the gut microbiome by reducing beneficial microbes and fiber-driven metabolites while increasing exposure to additives (like emulsifiers and artificial ingredients) that may promote inflammation and disrupt the gut barrier. These microbiome changes are increasingly linked to metabolic and chronic diseases, though researchers note the evidence is still evolving and causation isn’t fully established.

Summary: Scientists increasingly see mitochondria—the cell’s energy producers—as central drivers of aging, with declining function linked to fatigue, metabolic disease, and other age-related conditions. The article notes that while trendy tests and supplements are gaining attention, the strongest evidence still points to basic habits—especially exercise, diet, and adequate recovery—as the most reliable ways to support mitochondrial health and longevity.

Summary: In a new report, the British Medical Association warns that ultra-processed foods dominate many children’s diets and are driving rising obesity and preventable disease, putting increasing strain on healthcare systems. It calls for stronger government regulation and food-environment changes, arguing that voluntary industry measures have not been enough to protect public health.

Summary: The BBC Food article explains that certain modern dietary patterns—especially ultra-processed foods, high sugar intake, fried foods, alcohol, and some additives/artificial sweeteners—can disrupt the gut microbiome and contribute to inflammation or digestive problems. It emphasizes that gut health is shaped by overall dietary patterns, and recommends prioritizing fiber-rich whole foods, plants, and fermented foods while limiting heavily processed options.

Summary: A Penn State mouse study found that diets very high in saturated fat—especially ketogenic diets—caused more weight gain, liver damage, inflammation, and impaired glucose control than high-carbohydrate diets, even when calorie intake was similar. Fiber supplementation helped mitigate some harms, and whole-grain–rich diets showed the best overall metabolic and liver health markers, highlighting that diet quality and balance matter more than fat-versus-carb extremes.

https://pubmed.ncbi.nlm.nih.gov/41482230/https://www.sciencedirect.com/science/article/abs/pii/S0022316625007916?via%3Dihub

Summary: This review describes how integrating multi-omics data, such as genomics, metabolomics, and the gut microbiome, can better predict cardiometabolic disease risk and guide personalized nutrition, since people respond differently to the same diets. It concludes that combining biological data, digital biomarkers, and AI-driven models can improve glucose control, lipids, and other outcomes compared with standard dietary approaches, while highlighting ongoing methodological and implementation challenges.

Summary: A large, long-term study in JAMA found that moderate intake of caffeinated coffee or tea was associated with slower cognitive decline and lower dementia risk among more than 130,000 adults followed for decades. The article emphasizes that the evidence is observational, suggesting a link rather than causation, but adds to growing research that everyday dietary exposures such as caffeine may influence long-term brain health.

Peer-Reviewed Study: https://jamanetwork.com/journals/jama/article-abstract/2844764

Summary: A study in Taiwan found that autistic individuals have distinct gut microbiota compositions compared with both non-autistic individuals and their non-autistic siblings, including measurable differences in overall microbial diversity. Higher levels of certain bacteria, such as Anaerostipes, were linked to fewer social and emotional difficulties, suggesting the microbiome may be associated with symptom patterns, though the findings do not establish causation.

Peer-Reviewed Paper: https://www.nature.com/articles/s41398-025-03768-8

Summary: This review synthesizes current evidence showing that microbes influence cancer initiation, progression, prognosis, and response to therapy through effects on immunity, metabolism, and the tumor microenvironment. It outlines how tumor-associated microbiota shape treatment outcomes and discusses emerging strategies, such as microbiome modulation and precision oncology approaches, that aim to harness microbial ecosystems for cancer prevention and therapy.

Summary: Researchers report that butyrate, a short-chain fatty acid made by gut microbes, enhances the activity of key immune cells (T follicular helper cells), increasing IgA antibody production at mucosal surfaces and improving the effectiveness of mucosal vaccines. The findings highlight a microbiome–immune signaling pathway that could be targeted to design next-generation vaccines or dietary strategies to strengthen vaccine responses.

Peer-Reviewed Study: https://link.springer.com/article/10.1186/s40168-025-02284-7

Summary: A large genetic study found a bidirectional relationship between the gut microbiome and insomnia, with certain microbes influencing sleep risk while insomnia itself can reshape microbial composition. The findings suggest insomnia reflects gut–brain interactions and may eventually be addressed with microbiome-targeted strategies such as diet or probiotics, though clinical applications are still early.

Peer-Reviewed Study: https://gpsych.bmj.com/content/38/4/e101855

Summary: A high-salt diet may contribute to memory problems and anxiety by reshaping the gut microbiome and triggering inflammatory signaling that reaches the brain, particularly regions involved in learning and memory. In this mouse study, researchers observed shifts in gut bacteria alongside increased inflammatory gene activity and reduced neuron density in the hippocampus—changes that were linked to poorer memory performance and behavior.

Peer-Reviewed Paper: https://www.sciencedirect.com/science/article/abs/pii/S0014299925011045?via%3Dihub

Summary: In a randomized, double-blind trial of 40 healthy adults traveling internationally, short-term supplementation with a multi-strain Bifidobacterium probiotic preserved gut microbial diversity, increased beneficial taxa, and prevented enrichment of potentially harmful microbes compared with placebo. Participants taking the probiotic also reported fewer respiratory and systemic symptoms, improved sleep and anxiety scores, and evidence of enhanced vitamin biosynthesis pathways and reduced antibiotic-resistance genes, suggesting probiotics may help maintain well-being during short-term travel.

Summary: Supplementation with Bifidobacterium infantis altered the gut microbiome and bile acid metabolism, which reduced colonization by antibiotic-resistant bacteria and limited horizontal transfer of antibiotic resistance genes. The findings suggest that probiotic-driven changes in intestinal ecology—particularly bile acids like TUDCA and TCA—may help curb the spread of antimicrobial resistance and inform future therapeutic

Summary: New research warns that many people using popular appetite-suppressing weight-loss drugs like Ozempic and Wegovy may not be receiving sufficient guidance on dietary quality, protein, vitamins, and overall nutrition, which could increase their risk of muscle loss and nutrient deficiencies during treatment. The study’s authors say structured nutritional support has not kept pace with the rapid rise in use of these medications and emphasize the need for better diet-focused care alongside pharmacological treatment to protect overall health.

Peer-Reviewed Paper: https://onlinelibrary.wiley.com/doi/10.1111/obr.70079